Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Clinical Oncology Next Generation Sequencing Market to reach USD 1188.14 million by the end of 2030.

Global Clinical Oncology Next Generation Sequencing Market Size study & Forecast, by Technology (Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing) by Workflow (NGS Pre-Sequencing, NGS Sequencing, NGS Data Analysis), by Application (Screening, Companion Diagnostics, Others), by End Use (Hospitals, Clinics, Laboratories) and Regional Analysis, 2023-2030

Product Code: HLSB-14577101
Publish Date: 4-10-2023
Page: 200

Global Clinical Oncology Next Generation Sequencing Market is valued at approximately USD 370.0 million in 2022 and is anticipated to grow with a healthy growth rate of more than 15.70% over the forecast period 2023-2030. Clinical Oncology Next Generation Sequencing (NGS) refers to the application of advanced genomic sequencing technologies in the field of oncology, specifically for diagnosing and managing cancer. NGS is a high-throughput sequencing technique that enables the simultaneous analysis of multiple genes or genomic regions, providing comprehensive genetic information about a tumor. The Clinical Oncology Next Generation Sequencing market is expanding because of factors such as rising prevelance of cancer disorders, rising investment in research & development activities to invent solutions and growing healthcare expenditure triggering development of effective PM diagnostic & therapeutic procedure for cancer.

The increasing prevalence of cancer has spurred a rapid expansion of cancer research initiatives worldwide. NGS technology has become a cornerstone in cancer genomics research, facilitating large-scale genomic studies and collaborative efforts to unravel the complex genetic landscape of various cancer types. These research efforts contribute to the development of novel therapies, identification of new targets, and improved understanding of cancer biology. according to estimates from the International Agency for Research on Cancer (IARC), in year 2021 there were around 1.9 million new cancer cases across the world, and it is projected to increase at 27.5 million new cases by year 2040, worldwide. Moreover, key market players in the market are developing new platforms for the clinical uses of NGS in precision oncology resulting in market growth. For instance, a major company in the industry, In August 2022, Thermo Fisher Scientific launched NGS Analysis and Test Software CE-IVD (IVDD) in order to make precision oncology biomarker testing more widely available. Healthcare professionals can swiftly assess the outcomes of genomic tests thanks to this software. The software evaluates the variation data in light of pertinent data, such as supported recommendations, treatments, clinical studies, and peer-reviewed literature. Such developments in NGS clinical applications may increase consumer demand. In addition, technological advancements in next-generation sequencing (NGS) and growing adoption of companion diagnostics and personalized medicine is creating a lucrative opportunity in the market. However, the lack of computational efficiency for data management stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Clinical Oncology Next Generation Sequencing Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market players, rising research and development for precision oncology, rising investment in development of product, and rising government support to the healthcare industry. Asia Pacific is projected to have significant growth in the market space owing to factors such as rising prevelance of cancer, rising healthcare expenditure and rising government investment in oncology drug development activities.

Major market player included in this report are:
Illumina, Inc.
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd
Agilent Technologies, Inc.
Myriad Genetics, Inc.
Beijing Genomics Institute (BGI)
Perkin Elmer, Inc.
Oxford Nanopore Technologies
Paradigm Diagnostics, Inc.
PerkinElmer, Inc.

Recent Developments in the Market:
Ø In February 2023, F. Hoffmann-La Roche Ltd. and Janssen Biotech Inc. (Janssen) expanded their collaboration in order to create companion diagnostics for targeted treatments and to include a wide spectrum of companion diagnostics, including tissue- and blood-based biomarkers, digital pathology, and sequencing pathology.
Ø In June 2023, Illumina Inc., a producer of DNA sequencing and array-based technologies, developed the artificial intelligence system PrimateAI-3D, which had previously unheard-of accuracy in foretelling disease-causing genetic defects in individuals.

Global Clinical Oncology Next Generation Sequencing Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Technology, Workflow, Type, End-use, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Technology:
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Sequencing & Resequencing

By Workflow:
NGS Pre-Sequencing
NGS Sequencing
NGS Data Analysis
By Application:
Screening
Companion Diagnostics
Others
By End-use:
Hospitals
Clinics
Laboratories

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Clinical Oncology Next Generation Sequencing Market, by Region, 2020-2030 (USD Million)
1.2.2. Clinical Oncology Next Generation Sequencing Market, by Technology, 2020-2030 (USD Million)
1.2.3. Clinical Oncology Next Generation Sequencing Market, by Workflow, 2020-2030 (USD Million)
1.2.4. Clinical Oncology Next Generation Sequencing Market, by Application, 2020-2030 (USD Million)
1.2.5. Clinical Oncology Next Generation Sequencing Market, by End-use, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Clinical Oncology Next Generation Sequencing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Clinical Oncology Next Generation Sequencing Market Dynamics
3.1. Clinical Oncology Next Generation Sequencing Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevelance of cancer
3.1.1.2. Rising investment in research & development activities to invent solutions.
3.1.1.3. Growing healthcare expenditure triggering development of effective PM diagnostic & therapeutic procedure for cancer.
3.1.2. Market Challenges
3.1.2.1. Lack of computational efficiency for data management
3.1.3. Market Opportunities
3.1.3.1. Technological advancements in next-generation sequencing (NGS)
3.1.3.2. Growing adoption of companion diagnostics and personalized medicine
Chapter 4. Global Clinical Oncology Next Generation Sequencing Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Clinical Oncology Next Generation Sequencing Market, by Technology
5.1. Market Snapshot
5.2. Global Clinical Oncology Next Generation Sequencing Market by Technology, Performance – Potential Analysis
5.3. Global Clinical Oncology Next Generation Sequencing Market Estimates & Forecasts by Technology 2020-2030 (USD Million)
5.4. Clinical Oncology Next Generation Sequencing Market, Sub Segment Analysis
5.4.1. Whole Genome Sequencing
5.4.2. Whole Exome Sequencing
5.4.3. Targeted Sequencing & Resequencing
Chapter 6. Global Clinical Oncology Next Generation Sequencing Market, by Workflow
6.1. Market Snapshot
6.2. Global Clinical Oncology Next Generation Sequencing Market by Workflow, Performance – Potential Analysis
6.3. Global Clinical Oncology Next Generation Sequencing Market Estimates & Forecasts by Workflow 2020-2030 (USD Million)
6.4. Clinical Oncology Next Generation Sequencing Market, Sub Segment Analysis
6.4.1. NGS Pre-Sequencing
6.4.2. NGS Sequencing
6.4.3. NGS Data Analysis
Chapter 7. Global Clinical Oncology Next Generation Sequencing Market, by Application
7.1. Market Snapshot
7.2. Global Clinical Oncology Next Generation Sequencing Market by Application, Performance – Potential Analysis
7.3. Global Clinical Oncology Next Generation Sequencing Market Estimates & Forecasts by Application 2020-2030 (USD Million)
7.4. Clinical Oncology Next Generation Sequencing Market, Sub Segment Analysis
7.4.1. Screening
7.4.2. Companion Diagnostics
7.4.3. Others
Chapter 8. Global Clinical Oncology Next Generation Sequencing Market, by End-use
8.1. Market Snapshot
8.2. Global Clinical Oncology Next Generation Sequencing Market by End-use, Performance – Potential Analysis
8.3. Global Clinical Oncology Next Generation Sequencing Market Estimates & Forecasts by End-use 2020-2030 (USD Million)
8.4. Clinical Oncology Next Generation Sequencing Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Clinics
8.4.3. Laboratories
Chapter 9. Global Clinical Oncology Next Generation Sequencing Market, Regional Analysis
9.1. Top Leading Countries
9.2. Top Emerging Countries
9.3. Clinical Oncology Next Generation Sequencing Market, Regional Market Snapshot
9.4. North America Clinical Oncology Next Generation Sequencing Market
9.4.1. U.S. Clinical Oncology Next Generation Sequencing Market
9.4.1.1. Technology breakdown estimates & forecasts, 2020-2030
9.4.1.2. Workflow breakdown estimates & forecasts, 2020-2030
9.4.1.3. Application breakdown estimates & forecasts, 2020-2030
9.4.1.4. End-use breakdown estimates & forecasts, 2020-2030
9.4.2. Canada Clinical Oncology Next Generation Sequencing Market
9.5. Europe Clinical Oncology Next Generation Sequencing Market Snapshot
9.5.1. U.K. Clinical Oncology Next Generation Sequencing Market
9.5.2. Germany Clinical Oncology Next Generation Sequencing Market
9.5.3. France Clinical Oncology Next Generation Sequencing Market
9.5.4. Spain Clinical Oncology Next Generation Sequencing Market
9.5.5. Italy Clinical Oncology Next Generation Sequencing Market
9.5.6. Rest of Europe Clinical Oncology Next Generation Sequencing Market
9.6. Asia-Pacific Clinical Oncology Next Generation Sequencing Market Snapshot
9.6.1. China Clinical Oncology Next Generation Sequencing Market
9.6.2. India Clinical Oncology Next Generation Sequencing Market
9.6.3. Japan Clinical Oncology Next Generation Sequencing Market
9.6.4. Australia Clinical Oncology Next Generation Sequencing Market
9.6.5. South Korea Clinical Oncology Next Generation Sequencing Market
9.6.6. Rest of Asia Pacific Clinical Oncology Next Generation Sequencing Market
9.7. Latin America Clinical Oncology Next Generation Sequencing Market Snapshot
9.7.1. Brazil Clinical Oncology Next Generation Sequencing Market
9.7.2. Mexico Clinical Oncology Next Generation Sequencing Market
9.8. Middle East & Africa Clinical Oncology Next Generation Sequencing Market
9.8.1. Saudi Arabia Clinical Oncology Next Generation Sequencing Market
9.8.2. South Africa Clinical Oncology Next Generation Sequencing Market
9.8.3. Rest of Middle East & Africa Clinical Oncology Next Generation Sequencing Market

Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Company 1
10.1.2. Company 2
10.1.3. Company 3
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Illumina, Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Recent Developments
10.3.2. Thermo Fisher Scientific Inc.
10.3.3. F. Hoffmann-La Roche Ltd
10.3.4. Agilent Technologies, Inc.
10.3.5. Myriad Genetics, Inc.
10.3.6. Beijing Genomics Institute (BGI)
10.3.7. Perkin Elmer, Inc.
10.3.8. Oxford Nanopore Technologies
10.3.9. Paradigm Diagnostics, Inc.
10.3.10. PerkinElmer, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now